Fig. 4
From: Dectin-1/Syk signaling triggers neuroinflammation after ischemic stroke in mice
LAM treatment decreased the infarct volume and neurological impairment after a stroke. a, b LAM treatment significantly decreased the brain infarct volume in the ischemia group (n = 3/group; *P < 0.05 vs. ischemia group). c–e LAM treatment significantly enhanced the functional outcomes on days 3, 5, and 7 after stroke in the ischemia group compared with those of the ischemia and ischemia + saline groups (n = 9/group; *P < 0.05 vs. sham group; #P < 0.05 vs. ischemia group/ischemia + saline group). However, no significant difference was observed between the ischemic group and ischemic + saline group on days 3, 5 and 7 after a stroke. In addition, no significant difference was observed among these three groups on day 1 after the stroke